Continuous Monitoring for Safety

Once on the market, samples of every new lot of vaccine must be submitted to the FDA before it is sold. This ensures that each batch is as safe and effective as the last. Continuous monitoring of vaccines being administered ensures that each dose of the vaccine remains safe and effective, tracking any side-effects from the vaccine and responding to any potential safety issues.

The National Vaccine Injury Compensation Program (NVICP)
Although severe adverse events are rare, the NVICP was created to compensate people who may have been injured by vaccines. More information on this program including how to file a claim is available on the NVICP website.